A multiple sclerosis‐like disorder in patients with OPA1 mutations

Publisher： John Wiley & Sons Inc

E-ISSN： 2328-9503|3|9|723-729

ISSN： 2328-9503

Source： Annals Of Clinical And Translational Neurology, Vol.3, Iss.9, 2016-09, pp. : 723-729

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Appropriate Use of Interferon Beta-1a in Multiple Sclerosis

By Jacobs L.   Brownscheidle C.M.  

BioDrugs, Vol. 11, Iss. 3, 1999-03 ,pp. : 155-163

Adis International

Access to resources Recommend Favorite

Effects of inpatient rehabilitation in multiple sclerosis patients with moderate disability

By Vikman T.   Fielding P.   Lindmark B.   Fredrikson S.  

Advances in Physiotherapy, Vol. 10, Iss. 2, 2008-01 ,pp. : 58-65

Informa Healthcare

Access to resources Recommend Favorite

Infectious risk stratification in multiple sclerosis patients receiving immunotherapy

By  

Annals Of Clinical And Translational Neurology, Vol. 4, Iss. 12, 2017-12 ,pp. : 909-914

John Wiley & Sons Inc

Access to resources Recommend Favorite

Spotlight on Subcutaneous Recombinant Interferon- -1a (Rebif ® ) in Relapsing-Remitting Multiple Sclerosis

By Murdoch David   Lyseng-Williamson Katherine A.  

BioDrugs, Vol. 19, Iss. 5, 2005-01 ,pp. : 323-325

Adis International

Access to resources Recommend Favorite

Spotlight on Interferon- -1b in Relapsing-Remitting and Secondary Progressive Multiple Sclerosis

By Paul L. McCormack   Lesley J. Scott  

BioDrugs, Vol. 18, Iss. 5, 2004-01 ,pp. : 343-347

Adis International

Access to resources Recommend Favorite